Support for biopharmaceutical manufacturing in the U.S.; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
2025 · 3rd Quarter (July 1 - Sep 30)
FUJIFILM HOLDINGS AMERICA CORPORATION
Filed by CGCN GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CGCN GROUP, LLC
- Filing UUID
- f301a96b-4562-43f0-bd67-c9b347a43db9
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Literal federal measure citations: H.R. 10545
Issues related to domestic chemical manufacturing.
Issues related to trade and tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.